tripalmitin has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Govender, T; Jones, E; Kalhapure, R; Ojewole, E | 1 |
| Balasubramanyam, A; Gaubatz, J; Iyer, D; Jahoor, F; Pownall, HJ; Rehman, K; Sekhar, RV | 1 |
2 other study(ies) available for tripalmitin and HIV Coinfection
| Article | Year |
|---|---|
In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.
Topics: Adhesiveness; Administration, Buccal; Anti-HIV Agents; Chemistry, Pharmaceutical; Didanosine; Drug Delivery Systems; Elastic Modulus; HIV Infections; Humans; Lipids; Nanoparticles; Particle Size; Permeability; Poloxamer; Polymers; Tensile Strength; Triglycerides | 2014 |
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome.
Topics: Antiretroviral Therapy, Highly Active; Area Under Curve; Carbon Dioxide; Carbon Isotopes; Case-Control Studies; Chromatography, Thin Layer; Chylomicrons; Dietary Fats; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertriglyceridemia; Lipid Metabolism; Lipolysis; Male; Oxidation-Reduction; Postprandial Period; Triglycerides; Viral Load | 2005 |